Turchin, I., Brown‐Maher, T., Veillette, H., Croitoru, D. O., & Cullingham, K. (2026). Characteristics and Clinical Outcomes of Patients With Hidradenitis Suppurativa (HS) Treated With Bimekizumab: A Canadian Retrospective Chart Review. JEADV Clinical Practice, 5(2), 627. https://doi.org/10.1002/jvc2.70260
Chicago Style (17th ed.) CitationTurchin, Irina, Tracey Brown‐Maher, Hélène Veillette, David O. Croitoru, and Kyle Cullingham. "Characteristics and Clinical Outcomes of Patients With Hidradenitis Suppurativa (HS) Treated With Bimekizumab: A Canadian Retrospective Chart Review." JEADV Clinical Practice 5, no. 2 (2026): 627. https://doi.org/10.1002/jvc2.70260.
MLA (9th ed.) CitationTurchin, Irina, et al. "Characteristics and Clinical Outcomes of Patients With Hidradenitis Suppurativa (HS) Treated With Bimekizumab: A Canadian Retrospective Chart Review." JEADV Clinical Practice, vol. 5, no. 2, 2026, p. 627, https://doi.org/10.1002/jvc2.70260.